Corroborating this assumption, our data show that whole platelets, as well as tumour cell-induced releasates, evoked Treg differentiation from CD3/CD28/CD2 stimulated CD4+ T cells, although further cell types than regulatory T cells might contribute to IL-10 release from PBMCs. The gene discussed is CD2; the disease is neoplasm.